C. Giuliani, S. Hecht, J. Nuche, J. Farjat Pasos, J. Bernard, L. Tastet, R. Abu-Alhayja’a, J. Beaudoin, N. Côté, R. DeLarochellière, J. Paradis, M. Clavel, B. Arsenault, J. Rodes-Cabau, P. Pibarot
{"title":"人附睾蛋白4在经导管主动脉瓣植入术后的预后价值","authors":"C. Giuliani, S. Hecht, J. Nuche, J. Farjat Pasos, J. Bernard, L. Tastet, R. Abu-Alhayja’a, J. Beaudoin, N. Côté, R. DeLarochellière, J. Paradis, M. Clavel, B. Arsenault, J. Rodes-Cabau, P. Pibarot","doi":"10.1016/j.jcjd.2023.10.345","DOIUrl":null,"url":null,"abstract":"Plasma level of Human Epididymis protein 4 (HE4) has been shown to be associated with an increased risk of cardiac events in dilated and ischemic cardiomyopathies. The objective of this study was to examine the prognostic value of HE4 in patients undergoing transcatheter aortic valve implantation (TAVI).","PeriodicalId":93918,"journal":{"name":"Canadian journal of diabetes","volume":"321 7","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PROGNOSTIC VALUE OF HUMAN EPIDIDYMIS PROTEIN 4 FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION\",\"authors\":\"C. Giuliani, S. Hecht, J. Nuche, J. Farjat Pasos, J. Bernard, L. Tastet, R. Abu-Alhayja’a, J. Beaudoin, N. Côté, R. DeLarochellière, J. Paradis, M. Clavel, B. Arsenault, J. Rodes-Cabau, P. Pibarot\",\"doi\":\"10.1016/j.jcjd.2023.10.345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Plasma level of Human Epididymis protein 4 (HE4) has been shown to be associated with an increased risk of cardiac events in dilated and ischemic cardiomyopathies. The objective of this study was to examine the prognostic value of HE4 in patients undergoing transcatheter aortic valve implantation (TAVI).\",\"PeriodicalId\":93918,\"journal\":{\"name\":\"Canadian journal of diabetes\",\"volume\":\"321 7\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian journal of diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcjd.2023.10.345\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian journal of diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcjd.2023.10.345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
PROGNOSTIC VALUE OF HUMAN EPIDIDYMIS PROTEIN 4 FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION
Plasma level of Human Epididymis protein 4 (HE4) has been shown to be associated with an increased risk of cardiac events in dilated and ischemic cardiomyopathies. The objective of this study was to examine the prognostic value of HE4 in patients undergoing transcatheter aortic valve implantation (TAVI).